Neoadjuvant treatment strategies for hepatocellular carcinoma

被引：19
|
作者：
Xu, Lei [1 ]
Chen, Lin [1 ]
Zhang, Wei [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China
来源：
WORLD JOURNAL OF GASTROINTESTINAL SURGERY | 2021年 / 13卷 / 12期
关键词：
Hepatocellular carcinoma; Neoadjuvant therapy; Prognosis; Indications; Contraindications; PORTAL-VEIN EMBOLIZATION; DRUG-ELUTING BEADS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; GEMCITABINE PLUS OXALIPLATIN; RECURRENCE-FREE SURVIVAL; FATTY LIVER-DISEASE; INFERIOR VENA-CAVA; TRANSARTERIAL CHEMOEMBOLIZATION; Y-90; RADIOEMBOLIZATION; CONVENTIONAL CHEMOEMBOLIZATION;
D O I：
10.4240/wjgs.v13.i12.1550
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment.
引用
收藏
页码：1550 / 1566
页数：17
相关论文
共 50 条
  • [21] Nonsurgical Treatment for Localized Hepatocellular Carcinoma
    Kennedy, Andrew S.
    Sangro, Bruno
    CURRENT ONCOLOGY REPORTS, 2014, 16 (03)
  • [22] Treatment Strategies for Hepatocellular CarcinomaA Multidisciplinary Approach
    Lurje, Isabella
    Czigany, Zoltan
    Bednarsch, Jan
    Roderburg, Christoph
    Isfort, Peter
    Neumann, Ulf Peter
    Lurje, Georg
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [23] Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
    Raza, Ali
    Sood, Gagan K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4115 - 4127
  • [24] Ablative strategies for recurrent hepatocellular carcinoma
    Wang, Lin
    Liu, Bao-Xian
    Long, Hai-Yi
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) : 515 - 524
  • [25] How to Improve Treatment Outcomes for Hepatocellular Carcinoma of Intermediate and Advanced Stage
    Kim, Do Young
    Han, Kwang-Hyub
    DIGESTIVE DISEASES, 2012, 30 (06) : 598 - 602
  • [26] Current Treatment Strategies for Hepatocellular Carcinoma
    Aronsohn, Andrew
    Mohanty, Smruti R.
    CURRENT CANCER THERAPY REVIEWS, 2010, 6 (03) : 199 - 206
  • [27] Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma
    Lee, Ik Jae
    Seong, Jinsil
    ONCOLOGY, 2011, 81 : 123 - 133
  • [28] Evolution of Systemic Treatment for Hepatocellular Carcinoma: Changing Treatment Strategies and Concepts
    Moriguchi, Michihisa
    Kataoka, Seita
    Itoh, Yoshito
    CANCERS, 2024, 16 (13)
  • [29] Hepatocellular carcinoma: Current treatment strategies
    Shields A.
    Reddy K.R.
    Current Treatment Options in Gastroenterology, 2005, 8 (6) : 457 - 466
  • [30] Treatment strategies for hepatocellular carcinoma in cirrhosis
    W. Scott Helton
    Adrian Di Bisceglie
    Ravi Chari
    Myron Schwartz
    Jordi Bruix
    Journal of Gastrointestinal Surgery, 2003, 7 : 401 - 411
12345